PT93166A - Metodo para a producao de antigenios de celulas dos ilheus pancreaticos - Google Patents

Metodo para a producao de antigenios de celulas dos ilheus pancreaticos

Info

Publication number
PT93166A
PT93166A PT93166A PT9316690A PT93166A PT 93166 A PT93166 A PT 93166A PT 93166 A PT93166 A PT 93166A PT 9316690 A PT9316690 A PT 9316690A PT 93166 A PT93166 A PT 93166A
Authority
PT
Portugal
Prior art keywords
iddm
cell antigens
ica
pancreatic
cells
Prior art date
Application number
PT93166A
Other languages
English (en)
Other versions
PT93166B (pt
Inventor
Daniel Rabin
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of PT93166A publication Critical patent/PT93166A/pt
Publication of PT93166B publication Critical patent/PT93166B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT93166A 1989-02-17 1990-02-15 Metodo para a producao de antigenios de celulas dos ilheus pancreaticos PT93166B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (2)

Publication Number Publication Date
PT93166A true PT93166A (pt) 1990-08-31
PT93166B PT93166B (pt) 1997-11-28

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93166A PT93166B (pt) 1989-02-17 1990-02-15 Metodo para a producao de antigenios de celulas dos ilheus pancreaticos

Country Status (14)

Country Link
EP (1) EP0383129B1 (pt)
JP (1) JP2858467B2 (pt)
AT (1) ATE122394T1 (pt)
AU (1) AU626636B2 (pt)
CA (1) CA2010275C (pt)
DE (1) DE69019190T2 (pt)
DK (1) DK0383129T3 (pt)
ES (1) ES2072928T3 (pt)
FI (1) FI103730B (pt)
GR (1) GR3017019T3 (pt)
IE (1) IE66997B1 (pt)
IL (1) IL93397A (pt)
NO (1) NO306996B1 (pt)
PT (1) PT93166B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) * 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
JP2727377B2 (ja) 1990-09-07 1998-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 糖尿病自己抗体の検出方法
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
EP0585356A1 (en) * 1991-05-15 1994-03-09 Zymogenetics, Inc. Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
JPH07508503A (ja) * 1992-02-27 1995-09-21 ザ・ボード・オブ・トラステイーズ・オブ・ザ・リランド・スタンフオード・ジユニア・ユニバーシテイ 自己免疫性糖尿病のための初期抗原（ｅａｒｌｙ　ａｎｔｉｇｅｎ）
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
JP2001527403A (ja) * 1997-04-25 2001-12-25 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381518D1 (de) * 1982-01-22 1990-06-07 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
DE3687064T2 (de) * 1985-06-14 1993-11-11 Bristol Myers Squibb Co Verfahren zur identifizierung von mit gesteigerter diabetesgefahr assoziierten allelen.
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
CA1336954C (en) * 1987-06-24 1995-09-12 Howard L. Weiner Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
CA2010275A1 (en) 1990-08-17
IL93397A (en) 1997-06-10
IL93397A0 (en) 1990-11-29
AU626636B2 (en) 1992-08-06
FI900759A0 (fi) 1990-02-15
DE69019190D1 (de) 1995-06-14
IE66997B1 (en) 1996-02-21
FI103730B1 (fi) 1999-08-31
FI103730B (fi) 1999-08-31
IE900589L (en) 1990-08-17
PT93166B (pt) 1997-11-28
DE69019190T2 (de) 1995-09-14
GR3017019T3 (en) 1995-11-30
NO900474L (no) 1990-08-20
JP2858467B2 (ja) 1999-02-17
NO306996B1 (no) 2000-01-24
CA2010275C (en) 2000-08-29
EP0383129A3 (en) 1991-07-31
NO900474D0 (no) 1990-02-01
EP0383129B1 (en) 1995-05-10
JPH0347133A (ja) 1991-02-28
DK0383129T3 (da) 1995-10-09
AU4988390A (en) 1990-08-23
EP0383129A2 (en) 1990-08-22
ATE122394T1 (de) 1995-05-15
ES2072928T3 (es) 1995-08-01

Similar Documents

Publication Publication Date Title
PT93166A (pt) Metodo para a producao de antigenios de celulas dos ilheus pancreaticos
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
AU3192889A (en) T cell activation markers
NO904919L (no) Materiale for diagnostisering og behandling av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale.
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
NO975435L (no) Modifiserte/kimeriske proteiner samt anvendelse derav
ATE170562T1 (de) Ctl4a rezeptor, ihn enthaltenden fusionsproteine und deren verwendungen
AU1986588A (en) Growth hormone receptor
DE68925226T2 (de) Monoklonale Antikörper
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
EP0293827A3 (en) Assay for leishmaniasis
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
Beckman et al. Serum protein variations in monkeys
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970829

TE3A Change of address (patent)
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990228

NF3A Restitutio in integrum

Free format text: 19990830 RESTITUTIO IN INTEGRUM

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120829